Corcept Therapeutics Inc (CORT)
54.79
-1.66
(-2.94%)
USD |
NASDAQ |
Nov 14, 16:00
54.44
-0.35
(-0.64%)
After-Hours: 20:00
Corcept Therapeutics Cash and Short Term Investments (Quarterly): 380.34M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 380.34M |
| June 30, 2024 | 473.16M |
| March 31, 2024 | 410.76M |
| December 31, 2023 | 368.22M |
| September 30, 2023 | 355.22M |
| June 30, 2023 | 363.26M |
| March 31, 2023 | 465.06M |
| December 31, 2022 | 431.67M |
| September 30, 2022 | 396.26M |
| June 30, 2022 | 370.09M |
| March 31, 2022 | 345.53M |
| December 31, 2021 | 223.54M |
| September 30, 2021 | 361.33M |
| June 30, 2021 | 369.98M |
| March 31, 2021 | 372.96M |
| December 31, 2020 | 440.70M |
| September 30, 2020 | 428.79M |
| June 30, 2020 | 405.36M |
| March 31, 2020 | 307.32M |
| December 31, 2019 | 275.96M |
| September 30, 2019 | 231.64M |
| June 30, 2019 | 201.54M |
| March 31, 2019 | 186.90M |
| December 31, 2018 | 206.76M |
| September 30, 2018 | 195.19M |
| Date | Value |
|---|---|
| June 30, 2018 | 159.94M |
| March 31, 2018 | 125.36M |
| December 31, 2017 | 88.74M |
| September 30, 2017 | 75.16M |
| June 30, 2017 | 66.16M |
| March 31, 2017 | 52.77M |
| December 31, 2016 | 51.54M |
| September 30, 2016 | 47.86M |
| June 30, 2016 | 41.79M |
| March 31, 2016 | 40.74M |
| December 31, 2015 | 40.44M |
| September 30, 2015 | 36.45M |
| June 30, 2015 | 37.05M |
| March 31, 2015 | 37.95M |
| December 31, 2014 | 24.25M |
| September 30, 2014 | 26.78M |
| June 30, 2014 | 33.97M |
| March 31, 2014 | 43.62M |
| December 31, 2013 | 54.88M |
| September 30, 2013 | 63.18M |
| June 30, 2013 | 72.22M |
| March 31, 2013 | 81.46M |
| December 31, 2012 | 93.03M |
| September 30, 2012 | 101.63M |
| June 30, 2012 | 34.90M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
223.54M
Minimum
Dec 2021
473.16M
Maximum
Jun 2024
377.27M
Average
371.52M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 442.33M |
| ADMA Biologics Inc | 86.71M |
| Akebia Therapeutics Inc | 34.02M |
| Bioventus Inc | 43.07M |
| Alnylam Pharmaceuticals Inc | 2.780B |